Jun 22, 2015 at 10:00 | Source: Moneycontrol.com
Shares of HDFC Bank, HDFC, ICICI Bank, TCS, Axis Bank, Tata Motors, State Bank of India, Dr Reddy's Labs and Coal India jumped 1-2 percent. However, Wipro topped the selling list, falling 1.6 percent. ONGC, Reliance Industries and Bharti Airtel slipped 0.6-1 percent on profit booking.
Jun 22, 2015 at 08:17 | Source: CNBC-TV18
Wockhardt | Infosys | Dr Reddy's Labs | Indiabulls Real Estate | Merck | CRISIL | Britannia Industries | Jaiprakash Associates | NTPC | Tata Steel | Dish TV | Eicher Motors and Oberoi Realty are stocks, which are in the news today.
Jun 22, 2015 at 07:43 | Source: Moneycontrol.com
Asian market are higher on hopes of a Greek debt deal going through as the Greek Prime Minister Alexis Tsipras has offered a new package of reforms to creditors.
Jun 20, 2015 at 09:55 | Source: Moneycontrol.com
In the banking space, ICICI Bank shed 0.01 percent at USD 10.28 and HDFC Bank added 0.24 percent at USD 57.95.
Jun 19, 2015 at 13:36 | Source: PTI
On April 1, the drug firm had said that it would acquire select portfolio of established brands of UCB in India, Nepal, Sri Lanka and Maldives for Rs 800 crore.
Jun 19, 2015 at 08:25 | Source: Moneycontrol.com
Indian ADRs ended lower on Thursday. ICICI Bank added 0.16 percent and Tata Motors jumped 0.64 percent.
Jun 18, 2015 at 12:33 | Source: CNBC-TV18
Sudarshan Sukhani of s2analytics.com recommends exiting Natco Pharma and advises buying Glenmark Pharma, Dr Reddy's Laboratories and Sun Pharma at lower levels.
Jun 18, 2015 at 09:15 | Source: Moneycontrol.com
ICICI Bank, Dr Reddy's Labs, Axis Bank, Coal India, BHEL, Asian Paints and BPCL gained 0.7-1.6 percent. However, Bharti Airtel lost 1.6 percent. Tata Steel, GAIL, Tata Power, Hero Motocorp, Yes Bank, Zee Entertainment and Power Grid were other losers.
Jun 18, 2015 at 08:25 | Source: Moneycontrol.com
Indian ADRs ended higher on Wednesday. ICICI Bank rose 0.25 percent and Dr Reddy's Laboratories gained 1.19 percent.
Jun 17, 2015 at 16:28 | Source: CNBC-TV18
Naveen Kulkarni, co-head, research at Phillip Capital is of the view that Aurobindo Pharma and Biocon are the top picks from the pharma space.